Dose-dependent effects of combined IGF-I and TGF-β1 application in a sheep cervical spine fusion model

European Spine Journal

Volumn 12, Issue 5, 2003, Pages 464-473

  Kandziora, F ^a   Pflugmacher, R ^a   Scholz, M ^a   Schafer J ^a   Schollmeier, G ^a   Schmidmaier, G ^a   Duda, G ^a   Raschke, M ^a   Haas, N P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Animal model; Cervical spine; Dose; Growth factor; IGF I; Interbody fusion; Sheep; Surgery; TGF 1

Indexed keywords

DRUG CARRIER; FLUOROCHROME; POLYLACTIDE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BLOOD SAMPLING; BODY WEIGHT; BONE DENSITY; BONE MATRIX; BONE MINERAL; CALLUS; CERVICAL SPINE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INTERVERTEBRAL DISKECTOMY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; SHEEP; SPINE FUSION; TEMPERATURE;

ANIMALS; BONE MATRIX; CERVICAL VERTEBRAE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; INSULIN-LIKE GROWTH FACTOR I; OSTEOGENESIS; PROSTHESES AND IMPLANTS; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; SHEEP; SPINAL FUSION; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WEIGHT-BEARING; WOUND HEALING;

EID: 0242404619     PISSN: 09406719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00586-002-0483-x     Document Type: Article

References (61)

1. Ammann P, Bourrin S, Bonjour JP, Meyer JM, Rizzoli R (2000) Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and oestrogen deficiency. J Bone Miner Res 15:683-669
2. Aspenberg P, Turek T (1996) BMP-2 for intramuscular bone induction. Effect on squirrel monkeys is dependent on implantation site. Acta Orthop Scand 67:3-6
3. Beck L, Amento E, Xu Y, Deguzman L, Lee W, Nguyen T, Gillet N (1993) TGF-beta 1 induces bone closure of skull defects - temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. J Bone Miner Res 8: 753-761
4. Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS (1998) Laparoscopic anterior spinal arthrodesis with rh BMP-2 in a titanium interbody threaded cage. J Spinal Disord 11:95-101
5. Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA (1999) Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24:1179-1185
6. Boden SD, Zdeblick TA, Sandhu HS, Heim SE (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25:376-381
7. Bonewald LF, Schwartz Z, Swain LD, Ramirez V, Poser J, Boyan I (1990) Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor-beta in osteosarcoma cultures. J Cell Physiol 145:200-206
8. Canalis E, Pash J, Gabbitas B, Rydziel S, Varghese S (1993) Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures. Endocrinology 133: 33-38
9. David SM, Gruber HE, Mayer RA Jr, Murakami T, Tabor OB, Howard BA, Wozney JM, Hanley EN Jr (1999) Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers. Spine 24:1973-1979
10. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL (1993) Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387
11. Elford PR, Lamberts SW (1990) Contrasting modulation by transforming growth factor-beta 1 of insulin like growth factor-I production in osteoblasts and chondrocytes. Endocrinology 127:1635-1639
12. Fischgrund JS, James SB, Chabot MC, Hankin R, Herkowitz HN, Wozney JM, Shirkhoda A (1997) Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 10:467-472
13. Fujimoto A, Tanizawa T, Nishida S, Yamamoto N, Soshi S, Endo N, Takahashi HE (1999) Local effects of transforming growth factor-beta 1 on rat calvaria: changes depending on the dose and the injection site. J Bone Miner Metab 17:11-17
14. Gabbitas B, Canalis E (1997) Growth factor regulation of insulin-like growth factor binding protein-6 expression in osteoblasts. J Cell Biochem 66:77-86
15. Grauer JN, Patel TC, Erulkar JS, Troiano NW, Panjabi MM, Friedlaender GE (2001) 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 26: 127-133
16. Hecht BP, Fischgrund JS, Herkowitz HN, Penman L, Toth JM, Shirkhoda A (1999) The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 24:629-636
17. Hermann R, Schmidmaier G, Markl B, Resch A, Hahnel I, Stemberger A, Alt E (1999) Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 82:51-57
18. Hock J, Centrella M, Canalis E (1998) Insulin like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254-260
19. Hoshi K, Amizuka N, Sakou T, Kurokawa T, Ozawa H (1997) Fibroblasts of spinal ligaments pathologically differentiate into chondrocytes induced by recombinant human bone morphogenetic protein-2: morphological examinations for ossification of spinal ligaments. Bone 21:155-162
20. Illi OE, Feldmann CP (1998) Stimulation of fracture healing by local application of humeral factors integrated in biodegradable implants. Eur J Pediatr Surg 8:251-255
21. Isgaard J, Nilson A, Lindahl A, Jansson J, Isaksson O (1986) Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 250:367-372
22. Itoh H, Ebara S, Kamimura M, Tateiwa Y, Kinoshita T, Yuzawa Y, Takaoka K (1999) Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 24:1402-1405
23. Kandziora F, Kerschbaumer F, Starker M, Mittlmeier T (2000) Biomechanical assessment of transoral plate fixation for atlantoaxial instability. Spine 25: 1555-1561
24. Kandziora F, Pflugmacher R, Scholz M, Schnake K, Schröder R, Mittlmeier T (2001) Comparison between sheep and human cervical spines: an anatomic, radiographic, bone mineral density, and biomechanical study. Spine 26:1028-1037
25. Kandziora F, Pflugmacher R, Schäfer J, Duda G, Haas NP, Mittlmeier T (2001) Biomechanical comparison of cervical spine interbody fusion cages. Spine 26:1850-1857
26. Kandziora F, Schmidmaier G, Schollmeier G, Bail H, Pflugmacher R, Görke T, Wagner M, Raschke M, Mittlmeier T, Haas NP (2002) IGF-I and TGF-β1 application by a poly(D,L-lactide) coated cage promotes intervertebral bone matrix formation in the sheep cervical spine. Spine 27: 1710-1723
27. Kandziora F, Pflugmacher R, Scholz M, Knispel C, Killer T, Schiollmeier G, Bail H, Schmidmaier G, Duda G, Raschke M, Haas NP (2002) Comparison of BMP-2 and combined IGF-I/TGF-β1 application in a sheep cervical spine fusion model. Eur Spine J 11: 482-493
28. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H, Fujimura S (1997) Bone morphogenetic protein-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 60:291-296
29. Kveiborg M, Flyvbjerg A, Eriksen EF, Kaasem M (2001) Transforming growth factor beta 1 stimulates production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 169:549-561
30. Laursen M, Hoy K, Hansen ES, Gelineck J, Christensen FB, Bunger CE (1999) Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J 8: 485-490
31. Lind M (1998) Growth factor stimulation on bone healing. Effects on osteoblasts, osteotomies, and implants fixations. Acta Orthop Scand Suppl 283:2-37
32. Lind M, Schuhmacker B, Soballe K, Keller J, Melson F, Bunger C (1993) Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Act Orthop Scand 64:553-556
33. Ma ZJ, Misawa H, Yamaguchi M (2001) Stimulatory effect of zinc on insulin-like growth and transforming growth factor beta 1 production with bone growth of new-born rats. Int J Mol Med 8:623-628
34. Martin GJ Jr, Boden SD, Marone MA, Marone MA, Moskovitz PA (1999) Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12:179-186
35. Meyer RA Jr, Gruber HE, Howard BA, Tabor OB Jr, Murakami T, Kwiatkowski TC, Wozney JM, Hanley EN Jr (1999) Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine 24:747-754
36. Mimatsu K, Kishi S, Hashizume Y (1997) Experimental chronic compression on the spinal cord of the rabbit by ectopic bone formation in the ligamantum flavum with bone morphogenetic protein. Spinal Cord 35:740-746
37. Mohan S, Baylink D (1991) Bone growth factors. Clin Orthop Rel Res 263:30-48
38. Nielson H, Isgaard J, Lindahl A, Peterson L, Isaksson O (1987) Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats. Calcif Tissue Int 40:91-96
39. Noda M, Camilliere JJ (1989) In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124:2991-2994
40. O'Keefe RJ, Crabb ID, Puzas JE, Rosier RN (1994) Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. J Orthop Res 12:299-310
41. Panagakos FS (1994) Transforming growth factor alpha stimulates chemotaxis of osteoblasts and osteoblast-like cells in vitro. Biochem Mol Biol Int 33:643-650
42. Pfeilschifter J, Oechsner M, Naumann A, Gronwald R, Minne H, Ziegler R (1990) Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet derived growth factor and transforming growth factor beta. Endocrinology 127:69-75
43. Pfeilschifter J, Laukhuf F, Muller Beckmann B, Blim WF, Pfister H, Ziegler R (1995) Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96:767-774
44. Richman C, Baylink DJ, Lang K, Dony C, Mohan S (1999) Recombinant human insulin-like growth factor-binding protein 5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140:4699-4705
45. Roberts A, Sporn M, Bolander M (1990) Transforming growth factor-beta and the initiation of chondrogenesis in the rat femur. J Cell Biol 110: 2195-2207
46. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegen EN, Liu D, Delamater RB, Dawson EG (1996) Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21:2115-2122
47. Sandhu HS, Kanim LE, Toth JM, Kabo Jm, Liu D, Delamarter RB, Dawson EG (1997) Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 22: 1171-1180
48. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Biodegradable poly-(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mat Res 58:449-455
49. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Local application of growth factors (insulin-like growth factor-I and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 28: 341-350
50. Steinbrech DS, Mehrara BJ, Rowe NM, Dudziak ME, Luchs JS, Saadeh PB, Gittes GK, Longaker MT (2000) Gene expression of TGF-beta, TGF-beta receptor, and extracellular matrix proteins during membranous bone healing in rats. Plast Reconstr Surg 105:2028-2038
51. Terrell TG, Working PK, Chow CP, Green JD (1993) Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol 34B:43-67
52. Thaller S, Hoyt J, Tesluck H, Holmes R (1993) The effect of insulin growth factor-I on calvarial sutures in Sprague-Dawley rat. J Craniofac Surg 4:35-39
53. Tremollieres FA, Strong DD, Baylink DJ, Mohan S (1991) Insulin-like growth factor II and transforming growth factor beta 1 regulate insulin-like growth factor I secretion in mouse bone cells. Acta Endocrinol 125:538-546
54. Trippel S, Coutts R, Einhorn T, Mundy R, Rosenfeld R (1996) Growth factors as therapeutic agents. J Bone Joint Surg Am 78:1272-1286
55. Urist MR (1965) Bone: formation by autoinduction. Science 150:893-899
56. Wilton P (1992) Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on insulin-like growth factor I treatment in growth hormone insensitivity syndromes. Acta Paediatr Suppl 383: 137-142
57. Yaeger PC, Masi TL, de Oritz JL, Binette F, Tubo R, Mc Pherson J (1997) Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of Type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res 15:318-325
58. Yamada Y, Harada A, Hosoi T, Miyauchi A, Ikeda K, Otha H, Shiraki M (2000) Association of transforming growth factor beta 1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J Bone Miner Res 15:415-420
59. Yeh LC, Adamo ML, Olson MS, Lee JC (1997) Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation proliferation. Endocrinology 138:4181-4190
60. Zdeblick TS, Ganayem AJ, Rapoff AJ, Swain C, Bassett T, Cooke ME, Markel M (1998) Cervical interbody fusion cages. An animal model with and without bone morphogenetic protein. Spine 23:758-765
61. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO (1997) Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79: 1778-1790